General Commentary
Published on 17 Nov 2022
Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2
in Neuromuscular Disorders and Peripheral Neuropathies

- 1,783 views
- 1 citation
General Commentary
Published on 17 Nov 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Brief Research Report
Published on 15 Nov 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Case Report
Published on 14 Nov 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Case Report
Published on 24 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Original Research
Published on 21 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Perspective
Published on 21 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Brief Research Report
Published on 20 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Case Report
Published on 19 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Original Research
Published on 18 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Review
Published on 18 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Original Research
Published on 17 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Review
Published on 13 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Original Research
Published on 05 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Brief Research Report
Published on 05 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Systematic Review
Published on 05 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies
Systematic Review
Published on 03 Oct 2022
in Neuromuscular Disorders and Peripheral Neuropathies